Ivivi Technologies, Inc. Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida

NORTHVALE, N.J.--(BUSINESS WIRE)--Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technology, today announced that it has completed enrollment in its 30 patient, double-blind, randomized, placebo-controlled clinical trial utilizing the Company’s pulsed electromagnetic field (PEMF) technology to treat patients with ischemic cardiomyopathies. The trial is being conducted at The Cleveland Clinic Florida, an affiliate of the Cleveland Clinic.